Seaport Therapeutics Said to Raise $255 Million in IPO
Source ↗
👁 0
💬 0
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly $255 million in an upsized US initial public offering that priced at the top of its marketed range, according to people familiar with the matter.
Comments (0)